Human Growth Hormone - Blood
Research News and Information

Sunday, November 22, 2009

Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly.

30 Oct 2009 Somatostatin analogs (SSA) with their potent antisecretory and antiproliferative effects are the main medical treatment option for patients with neuroendocrine tumors, such as gastroenteropancreatic and acromegaly-associated growth hormone secreting ... Read more...

[Treatment of pituitary adenomas]

25 Sep 2009 According to epidemiological studies, the prevalence of pituitary adenomas is 16.5% and the majority of them are "incidentalomas". The symptoms of pituitary disorders are often non-specific; disturbances of pituitary function, compression symptoms, ... Read more...

Basal, pulsatile, entropic (patterned), and spiky (staccato-like) properties of ACTH secretion: impact of age, gender, and body mass index.

13 Sep 2009 BACKGROUND: Age, gender, and BMI determine ultradian modes of LH and GH secretion, viz., pulsatile, basal, pattern-defined regularity [approximate entropy (ApEn)] and spikiness (sharp, brief excursions). Whether the same determinants apply to ACTH ... Read more...

Latest indexed articles for 'Human Growth Hormone - Blood'

These are the very latest articles for this heading:

• Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly. 30 Oct 2009
• [Treatment of pituitary adenomas] 25 Sep 2009
• Basal, pulsatile, entropic (patterned), and spiky (staccato-like) properties of ACTH secretion: impact of age, gender, and body mass index. 13 Sep 2009
• Diagnosis of growth hormone deficiency by using the arginine provocative test: is it possible to shorten testing time without altering validity? 30 Aug 2009
• Partial restoration of GH responsiveness to ghrelin in Cushing's disease after 6 months of ketoconazole treatment: comparison with GHRP-6 and GHRH. 18 Aug 2009
• Elastosonographic evaluation of thyroid nodules in acromegaly. 5 Aug 2009
• [Outcome of somatostatin analogue treatment in acromegaly] 31 Jul 2009
• Pituitary gland: Medical therapy for acromegaly: can we predict response? 30 Jul 2009
• Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: a prospective study. 19 Jul 2009
• Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity. 12 Jul 2009
• Association of thyroid gland volume, serum insulin-like growth factor-I, and anthropometric variables in euthyroid prepubertal children. 12 Jul 2009
• Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction. 5 Jul 2009
• The expression of androgen-regulated genes before and after a resistance exercise bout in younger and older men. 29 Jun 2009
• Excisional breast biopsy under local anesthesia: stress-related neuroendocrine, metabolic and immune reactions during the procedure. 29 Jun 2009
• Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance. 28 Jun 2009
• Effects of growth hormone and free fatty acids on insulin sensitivity in patients with type 1 diabetes. 28 Jun 2009
• Influence of gender on serum growth hormone, insulin-like growth factor-I and its binding protein-3 during aging. 22 Jun 2009
• Growth hormone receptor antagonist treatment reduces exercise performance in young males. 21 Jun 2009
• Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice. 31 May 2009
• Regulation of basal, pulsatile, and entropic (patterned) modes of GH secretion in a putatively low-somatostatin milieu in women. 31 May 2009

See a longer list of these articles.

Technical information about 'Human Growth Hormone'

Definition: A 191-amino acid polypeptide hormone secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR), also known as GH or somatotropin. Synthetic growth hormone, termed somatropin, has replaced the natural form in therapeutic usage such as treatment of dwarfism in children with growth hormone deficiency.

Chemical name: Somatotropin (human)

Registry Number: 12629-01-5

Descriptor UI: D019382

Alternative terms: Human Growth Hormone; Growth Hormone, Human; Somatotropin (Human); Somatropin (Human); hGH (Human Growth Hormone); Somatropin; Genotropin; Pharmacia Brand of Human Growth Hormone; Pharmacia Spain Brand of Human Growth Hormone; Genotonorm; Humatrope; Umatrope; Lilly Brand of Human Growth Hormone; Eli Lilly Brand of Human Growth Hormone; Irisfarma Brand of Human Growth Hormone; Maxomat; Sanofi Synthelabo Brand of Human Growth Hormone; Norditropin; Pisa Brand of Human Growth Hormone; Novo Nordisk Brand of Human Growth Hormone; Norditropin Simplexx; Norditropine; Zomacton; Ferring Brand of Human Growth Hormone; Omnitrope; Sandoz Brand of Human Growth Hormone; Recombinant Human Growth Hormone (Mammalian); r-hGH-M; r-hGH(m); Saizen; Allphar Brand of Human Growth Hormone; Serostim; Serono Brand of Human Growth Hormone; Cryo-Tropin; Cryo Tropin; CryoTropin; Cryopharma Brand of Human Growth Hormone; Nutropin; Hoffmann La-Roche Brand of Human Growth Hormone; Hoffmann La Roche Brand of Human Growth Hormone;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D06.472.699.631.525.425.875; D12.644.548.691.525.425.875;

History Note: 2003 (1997); for SEROSTIM use SOMATOTROPINS, RECOMBINANT (NM) 1996-2002; use NORDITROPIN (NM) 1992-1996

Technical Notes: GROWTH HORMONE, unspecified is also available; despite entry term, coordinate with RECOMBINANT PROTEINS for recombinant human growth hormone